Business United states

Martin Shkreli (8photo)

Written by

Martin Shkreli (/ˈskrɛli/; born April 1, 1983) is an American entrepreneur and financial and pharmaceutical executive. He is co-founder of the hedge fund MSMB Capital Management, co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin LLC, and founder and former CEO of Turing Pharmaceuticals AG. In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by 5,556 percent (from US$13.50 to US$750 per tablet).

On December 17, 2015, Shkreli was arrested by the FBI on charges of securities fraud and released on bail. He resigned as CEO of Turing Pharmaceuticals and was replaced by the company’s board chairman, Ron Tilles.



Personal life

Starting in 2008, Shkreli served as chairman of the board of directors of the National Albanian American Council, a nonprofit organization that advocates for Albanians and promotes peace and economic development for human rights in the Balkans. He continued in this role as of 2014




Shkreli was revealed as the winner of an auction for the Wu-Tang Clan album Once Upon a Time in Shaolin after the single copy of the album was sold via Paddle8 on November 24, 2015, for US$2 million to what was reported to be a “private American collector.”[105] On December 9, 2015, Bloomberg Businessweek identified Shkreli as the purchaser.



source: Shkreli resigns as CEO of Turi

https://www.forbes.comMartin Shkreli: ‘I Would’ve Raised Pric

https://abcnews.go.comTuring Pharmaceuticals CEO Martin

https://guardianlv.comMartin Shkreli Arrested for Securities’s Bad Boy Exec Paid $2 Milli

https://www.businessinsider.comWhy we need Martin Shkreli – Busines

https://www.attn.comWhy Martin Shkreli Might Actually Lea

(Visited 114 times, 1 visits today)
هاست رایگان

About the author